Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GNLN | Director Stock Option (right to buy) | Award | $0 | +11.5K | $0.00 | 11.5K | Mar 17, 2021 | Class A Common Stock | 11.5K | $5.71 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Explanatory Note: This amended Form 4 is being filed to correct the Form 4 filed on March 19, 2021 (the "Original Form 4"), which inadvertently reported the Black-Scholes value of the Stock Options awarded to the Reporting Person rather than the exercise price of the Stock Options. All other information previously reported in the Original Form 4, and restated in this amended Form 4, remains correct. |
F2 | The Reporting Person received a grant of stock options on March 17, 2021 under the Issuer's 2019 Equity Incentive Plan. These options vested 50% on the grant date and vest 50% on March 17, 2022, such that on March 17, 2022, the Reporting Person's Director Stock Options shall be 100% vested. |